Nexalin SVP exits with bonus and option perks
Nexalin Technology discloses the departure of a senior vice president and details a separation package including cash, equity vesting, and benefits.
Rhea-AI Filing Summary
Nexalin Technology, Inc. (NXL) reports that on August 28, 2026, Carolyn Shelton departed from her role as Senior Vice President of Quality, Regulatory, and Clinical Affairs. In connection with her departure, she entered into a separation agreement with the company.
The agreement provides one month of continued base salary, a $20,000 2026 bonus, accelerated vesting of her unvested stock options, up to two years to exercise vested options, and continued subsidy of health insurance premiums through September 30, 2026. In return, she provides a release of claims and agrees to confidentiality, non-disparagement, and cooperation provisions. The full agreement will be filed as an exhibit to Nexalin’s next periodic report.
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Executive departure date: August 28, 2026
2026 bonus under separation agreement: $20,000
Option exercise period: Up to 2 years
+2 more
5 metrics
Executive departure date
August 28, 2026
Date Carolyn Shelton departed as Senior Vice President of Quality, Regulatory, and Clinical Affairs
2026 bonus under separation agreement
$20,000
Cash bonus payable to Carolyn Shelton as part of her separation package
Option exercise period
Up to 2 years
Time allowed for Ms. Shelton to exercise her vested stock options after departure
Health insurance subsidy period end
September 30, 2026
End date through which the company will subsidize Ms. Shelton’s health insurance premiums
Continued base salary period
1 month
Duration of continued base salary provided under the separation agreement
Key Terms
separation agreement, accelerated vesting, release of claims, non-disparagement, +1 more
5 terms
separation agreement financial
"In connection with her departure, Ms. Shelton and the Company entered into a separation agreement"
A separation agreement is a written contract that spells out the financial and legal terms when an employee and a company part ways, such as final pay, severance, continued benefits, confidentiality, and any release of claims. For investors, it matters because these agreements determine immediate costs, potential future liabilities, and whether departing staff are restricted from competing or disclosing information—factors that can affect a company’s cash flow, risk profile, and leadership continuity.
accelerated vesting financial
"provides for one month of continued base salary, a 2026 bonus of $20,000, accelerated vesting of her unvested stock options"
A contract feature that makes stock awards, options, or restricted shares become owned or exercisable earlier than the original schedule. It shortens or cancels the waiting period so recipients can sell, transfer, or exercise their equity sooner — think of a timed lock that is unlocked ahead of schedule. It matters to investors because it changes when shares enter the market, who controls them, and how much dilution or ownership concentration happens.
release of claims regulatory
"Ms. Shelton agreed to a release of claims in favor of the Company"
non-disparagement regulatory
"standard confidentiality, non-disparagement, and cooperation provisions"
A non-disparagement provision is a promise in an agreement that one party will not make negative public statements about the other, like a vow to avoid “badmouthing” a business or its leaders. Investors care because such promises protect reputation and can limit public criticism that might affect a company’s stock price, signal unresolved disputes, or introduce legal risk if enforcement leads to further costs or constrained disclosure.
Emerging Growth Company regulatory
"Emerging Growth Company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
What executive change did Nexalin Technology (NXL) announce on August 28, 2026?
Nexalin Technology announced that Carolyn Shelton departed from her role as Senior Vice President of Quality, Regulatory, and Clinical Affairs on August 28, 2026, and that her departure is governed by a negotiated separation agreement.
What cash benefits does the separation agreement provide to Carolyn Shelton at NXL?
The separation agreement provides Ms. Shelton with one month of continued base salary and a 2026 bonus of $20,000. These are in addition to equity-related accommodations and benefits subsidies described in the agreement.
How are Carolyn Shelton’s stock options treated under the Nexalin Technology separation agreement?
The agreement provides for accelerated vesting of Ms. Shelton’s unvested stock options and allows her up to two years to exercise her vested options, extending the time frame she has to potentially realize value from those awards.
What health insurance benefits does Nexalin Technology continue for Carolyn Shelton?
Nexalin Technology agreed to continue subsidizing Ms. Shelton’s health insurance premiums through September 30, 2026, providing a defined period of continued benefits support following her departure from the company.
What obligations does Carolyn Shelton assume under the separation agreement with NXL?
In exchange for the severance benefits, Ms. Shelton agrees to a release of claims in favor of Nexalin, along with standard confidentiality, non-disparagement, and cooperation provisions set out in the separation agreement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
